Abstract
Lymphatic filariasis caused mainly by infection fromWuchereria bancrofti andBrugia malayi remains as the major cause of clinical morbidity in tropical and subtropical countries. Development of vaccine against filarial infection can act as additional measure to the existing therapeutic and vector control methods in the control of this disease. The main hurdles in the development of anti-filarial vaccine are the strict primate specificity ofWuchereria bancrofti, the paucity of parasite material, the diversity of clinical manifestations and their associated complex immune responses, lack of clear understanding on host-parasite interactions and the mechanisms involved in protective immunity. However in the past few years, the information generated in immuno-epidemiological studies, correlated with observations in experimental animals suggests that a filarial vaccine is feasible. Initially live irradiated infective larvae have been successfully used to induce high level of protective immunity in several animal models. Applying diverse strategies, variety of purified or recombinant filarial antigens have been explored for their ability to induce protection in different host-parasite systems. Some of these targeted filarial antigens induced high level of resistance in experimental animals against challenge infections. More focussed studies on thorough characterization of parasitological and immunological changes associated with resistance induced by such candidate protective antigens and on delivery mechanisms and safety aspects will be crucial in their selection for possible use in humans.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
World Health Organization. (1994) Lymphatic Filariasis Infection & Disease Control Strategies: Report of a WHO/CTD/TDR consultative meeting 1.
Harinath, B.C., Reddy, M.V.R., Alli, R., Mehta, V.K., Chaturvedi, P., Patond, K.R., Kalantri, S.P. and Gupta, R.K.C. (1999) Immunomonitoring followed by Optimal DEC Therapy for successful management of clinical filariasis in an endemic area. Indian J. Clin. Biochem. 14, 100–108.
Ottesen, E.A. (1980) Immunopathology of lymphatic filariasis. Springer Semin Immunopathol. 2, 373–385.
Harinath, B.C. and Reddy, M.V.R. (1997) Diagnosis and Immunomonitoring in the successful management of bancroftian filariasis. J. Parasitic. Dis. 21, 41–51.
Weil, G. J., Ramzy, R. M. R., Chandrashekar, R., Gad, A. M., Lowrie, Jr, R. C. and Faris, R. (1996) Parasite antigenemia without microfilaremia. Amer. J. Trop. Med. Hyg. 55, 333–337.
Philipp, M., Davis, T.B., Storey, N and Carlow, C.K.S. (1988) Immunity in filariasis: Perspectives for vaccine development. Annu. Rev. Microbiol. 42, 685–716.
Grieve, R.B., Wisnewski, N., Frank, G.R. and Tripp, C.A. (1995) Vaccine Design. The subunit and Adjuvant Approach. Edited by Michael F. Powell and Mark J. Newman Plenum Press, New York.
Ottesen, E.A. (1984) Immunological aspects of lymphatic filariasis and onchocerciasis in man. Trans. R. Soc. Trop. Med. Hyg. 78, 9–18.
Day, K.P. (1991) The endemic normal in lymphatic filariasis. A static concept. Parasitol. Tody 7, 341–343.
Freedman, D.O., Nutman, T.B. and Ottesen, E.A. (1989) Protective immunity in bancroftian filariasis: Selective recognition of a 43 kD larval stage antigen by infection free individuals in an endemic area. J. Clin. Invest. 83, 14–22.
Nutman, T.B. (1989) Protective immunity in lymphatic filariasis. Exp. Parasitol. 68, 248–252.
Day, K.P., Gregory, W.F. and Maizels, R.M. (1991) Age specific acquisition of immunity to infective larvae in a bancroftian filariasis endemic area of Papua New Guinea. Parasite Immunol. 13, 277–290
Vanamali, P., Subramanian, S., Das, P.K., Pani S.P., Rajagopalan, P.K., Bundy, D.A.P. and Grenfell, B.T. (1989) Estimation of age-specific rates of acquisition and loss ofWuchereria bancrofti infection. Trans. R. Soc. Trop. Med. Hyg. 83, 689–693.
Denham, D.A., McGreevy, P.B., Suswillo, R.R. and Rogers, R. (1983) The resistance to re-infection of cats repeatedly inoculated with infective larvae ofBrugia pahangi. Parasitology 86, 11–18.
Grenfell, B.T., Michael, E. and Denham, D. (1991) A model for the dynamics of human lymphatic filariasis. Parasitol. Today 7, 318–323.
Barthold, E. and Wenk, P. (1992) Dose-dependent recovery of adultAcanthocheilonema viteae (Nematoda: Filarioidea) after single and trickle inoculations in jirds. Parasitol. Res. 78, 229–234.
Rajasekariah, G.R., Monteiro, Y.M., Nelto, A., Deshpande, L. and Subrahmanyam, D. (1989) Protective immune responses with trickle infections of the third stage filarial larvae,Wuchereria bancrofti in mice. Clin. Exp. Immunol. 78, 292–298.
Maizels, R. M. and Lawrence, R. A. (1991) Immunological tolerance. The key feature in human filariasis. Parasitol. Today 7, 271–276.
Philipp, M., Worms, M. J., Maizels, R. M. and Ogilivie, B. M. (1984) Rodent Models of filariasis. Contemp. Trop. Immunobiol 12, 275–321.
Palmieri, J.R., Conner, D.H., Purnomo, Dennis, D.T. and Marwoto, H. (1982). Experimental infection ofWuchereria bancrofti in the silvered leaf monkey Presbytis Cristatus Eschscholtz 1821. J. Helminthol 56, 243–245.
Piessens, W.F., Wadee, A.A. and Kurniawan, L. (1987) Regulation of immune responses in lymphatic filariasis. Ciba Foun. Symp. 127, 164–179.
Partono, F. (1982) Elephantiasis and its relation to filarial immunity. Southeast Asian J. Trop. Med. Public Health. 13, 275–279.
Ottesen, E. A., Mendell, N. R., mac Queen, J. M., Weller, P. F., Amos, D. B. et al (1981) Familial predisposition to filarial infection-not linked to HLA-A or-B locus specificities. Acta Trop. 38, 205–216.
Wong, M. M., Fredericks, H. J. and Ramachandran, C. P. (1969) Studies on immunization againstBrugia malayi infection in the rhesus monkey. Bull. WHO 40, 493–501.
Ah, H. S., Mc Call, J. W. and Thompson, P. E. (1974) A simple method for isolation ofBrugia pahangi andBrugia malayi microfilariae. Int. J. Parasitol. 4, 677–679.
Oothuman, P., Denham, D. A., Mc Greevy, P. B., Nelson, G. S. and Rogers, R. (1979) Successful vaccination of cats againstBrugia pahangi with larvae attenuated by irradiation with 10 krad cobalt 60. Parasite. Immunol. 1, 209–216.
Chusattayanond, W. and Denham, D. A. (1986) Attempted vaccination of jirds againstBrugia pahangi with radiation attenuated infective larvae. J. Helminthol. 60, 149–155.
Bancroft, A. J. and Devaney, E. (1993) The analysis of the humoral response of the BALB/c mouse immunized with radiation attenuated third stage larvae ofBrugia pahangi. Parasite Immunol. 15, 153–162.
Yates, J. A. and Higashi, G. I. (1985)Brugia malayi vaccination of jirds with 60 cobalt attenuated infective stage larvae protects against homologous challenge. Amer. J. Trop. Med. Hyg. 34, 1132–1137.
Hayashi, Y., Nogami, S., Nakamura, M., Shirasaka, A. and Noda, K. (1984) Passive transfer of protective immunity againstBrugia malayi in BALB/c mice. Jpn. J. Exp. Med. 54, 183–187.
Abraham, D., Grieve, R. B., Holy, J. M. and Christensen, B. M. (1989) Immunity to larvalBrugia malayi in BALB/c mice: Protective immunity and inhibition of larval development. Amer. J. Trop. Med. Hyg. 40, 598–604.
Rao, Y.V.B.G., Mehta, K. and Subrahmanyam, D. (1977)Litomosoides carinii. Effect of irradiation on the development and immunogenicity of the larval forms. Exp. Parasitol. 43, 39–44.
Grieve, R. B., Abraham, D., Mika-Grieve, M. and Seibert, B. P. (1988) Induction of protective immunity in dogs to infection withDirofilaria immitis using chemically abbreviated infections. Amer. J. Trop. Med. Hyg. 39, 373–379.
Kazura, J. and Davis, R. S. (1982) SolubleBrugia malayi microfilarial antigens protect mice against challenge by an antibody dependent mechanism. J. Immunol. 128, 1792–1796.
Hayashi, Y., Nakagahi, K., Nogami, S., Harnmerberg, B. and Tanaka, H. (1989) Protective immunity againstBrugia malayi infective larvae in mice. Parameters of active and passive immunity. Amer. J. Trop. Med. Hyg. 41, 650–656.
Tanner, M. and Weiss, N. (1981)Dipetalonema viteae (Filarioidea): Evidence for a serum-dependent cytotoxicity against develo** third and fourth stage larvae in vitro. Acta Trop. 38, 325–328.
Mehta, K., Subrahmanyam, D. and Sindhu, R. K. (1981) Immunogenicity of homogenates of the developmental stages ofLitomosoides Carinii in albino rats. Acta Trop 38, 319–324
Kazura, J. W., Cicirello, H. and Forsyth, K. (1986) Differential recognition of a protective filarial antigen by antibodies from humans with bancroftian filariasis. J. Clin. Invest. 77, 1985–1992.
Cheirmaraj, K., Chenthamarahshan, V., Reddy, M. V. and Harinath, B. C. (1991) Immunoprophylaxis against filarial parasite,Brugia malayi: Potential of excretory-secretory antigens in inducing immunity. J. Biosci. 16, 209–216.
Cheirmaraj, K., Reddy, M. V. R. and Harinath, B. C. (1991) Differential reactivity of filarial antigens with human sera from bancroftian filariasis endemic zone. J. Biosci. 16, 199–208.
Chenthamarakshan, V., Reddy, M. V. R. and Harinath, B. C. (1995) Immunoprophylactic potential of a 120 kDaBrugia malayi adult antigen fraction, Bm A-2, in lymphatic filariasis. Parasite Immunology 17, 277–285.
Mehta, K., Sindhu, R. K., Subrahmanyam, D., Hopper, K. E. and Nelson, D. S. (1981) Antibody dependent cell-mediated effects in bancroftian filariasis. Immunology. 43, 117–123.
Chenthamarakshan, V., Reddy, M. V. R. and Harinath, B. C. (2000) A-43-kDa circulating filarial antigen fraction ofWuchereria bancrofti immunoprophylaxis againstBrugia malayi in jirds. Parasitology International. 48, 281–288.
Raghavan, N., Freedman, D.O., Fitzgerald, P.C., Uruceeh, T.R., Ottesen, E.A. and Nutman, T.B. (1994) Cloning and characterization of potentially protective chitinase like recombinant antigen fromW. bancrofti. Infect. Immun. 62, 1901–1908.
Wang, S. H., Zheng, H. J., Dissanayake, S., Cheng, W. F., Tao, Z. H., Lin, S. Z. and Piessens, W. F. (1997) Evaluation of Recombinant Chitinase and SXP1 antigens as Antimicrofilarial vaccines. Amer. J. Trop. Med. Hyg. 56, 474–481.
Li, B., Chandrashekar, R., Alvarez, R. M., Liftis, F. and Weil, G. J. (1991) Identification of paramyosin as a potential protective antigen againstBrugia malayi infection in jirds. Mol. Biochem. Parasitol. 49, 315–324.
Nanduri, J. and Kazura, J. W. (1989) Paramyosin-enhanced clearance ofBrugia malayi microfilaremia in mice. J. Immunol. 143, 3359–3363.
Li, B., Ramaswamy, C. and Weil, G. J. (1993). Vaccination with recombinant filarial paramyosin induces partial immunity toBrugia malayi infection in jirds. J. Immunol. 150, 1881–1885.
Li, B. W., Zhang, S., Curtis, K. C. and Weil, G. J. (1999) Immune responses toBrugia malayi paramyosin in rodents after DNA vaccination. Vaccine. 18, 76–81.
Peralta, M. E., Schmitz, K. K. and Rajan, T. V. (1999) Failure of highly immunogenic filarial proteins to provide host-protective immunity. Expt. Parasitol 94, 334–340.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reddy, M.V.R., Alli, R. & Harinath, B.C. Host protective immunity and vaccine development studies in lymphatic filariasis. Indian J Clin Biochem 15 (Suppl 1), 127–135 (2000). https://doi.org/10.1007/BF02867552
Issue Date:
DOI: https://doi.org/10.1007/BF02867552